News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
31,599 Results
Type
Article (3348)
Company Profile (17)
Press Release (28234)
Section
Business (7364)
Career Advice (577)
Deals (1505)
Drug Delivery (23)
Drug Development (4538)
Employer Resources (35)
FDA (792)
Job Trends (1240)
News (14581)
Policy (1570)
Tag
Academia (215)
Allergies (16)
Alliances (1761)
Alzheimer's disease (69)
Approvals (788)
Artificial intelligence (16)
Bankruptcy (11)
Best Places to Work (1116)
Biotechnology (15)
Breast cancer (16)
Cancer (129)
Cardiovascular disease (12)
Career advice (481)
Cell therapy (29)
Clinical research (3588)
Collaboration (24)
COVID-19 (208)
Data (121)
Diabetes (20)
Diagnostics (238)
Diversity, equity & inclusion (12)
Drug pricing (16)
Earnings (3105)
Employer resources (35)
Events (4070)
Executive appointments (10)
FDA (846)
Funding (28)
Gene therapy (19)
GLP-1 (49)
Government (259)
Healthcare (1158)
Infectious disease (222)
Interviews (118)
IPO (816)
Job creations (180)
Job search strategy (398)
Layoffs (22)
Legal (284)
Liver cancer (14)
Lung cancer (20)
Lymphoma (11)
Management (11)
Manufacturing (17)
Medical device (518)
Medtech (518)
Mergers & acquisitions (706)
Metabolic disorders (41)
Neuroscience (101)
NextGen Class of 2024 (407)
Non-profit (385)
Northern California (105)
Obesity (26)
Opinion (42)
People (1964)
Phase I (1027)
Phase II (1500)
Phase III (1412)
Pipeline (42)
Policy (13)
Postmarket research (100)
Preclinical (447)
Prostate cancer (15)
Radiopharmaceuticals (18)
Rare diseases (13)
Real estate (147)
Recruiting (13)
Regulatory (1129)
Reports (22)
Research institute (154)
Resumes & cover letters (82)
Southern California (107)
Special edition (13)
Startups (141)
United States (853)
Vaccines (54)
Weight loss (22)
Date
Today (6)
Last 7 days (34)
Last 30 days (174)
Last 365 days (2513)
2024 (2490)
2023 (2175)
2022 (3168)
2021 (3389)
2020 (3051)
2019 (2894)
2018 (2072)
2017 (1626)
2016 (1651)
2015 (1600)
2014 (1069)
2013 (828)
2012 (887)
2011 (889)
2010 (714)
Location
Africa (116)
Asia (2411)
Australia (408)
California (233)
Canada (77)
China (39)
Connecticut (19)
Europe (4462)
Florida (44)
Illinois (42)
Indiana (21)
Maryland (50)
Massachusetts (111)
Minnesota (13)
New Jersey (73)
New York (64)
North Carolina (44)
Northern California (105)
Pennsylvania (62)
South America (127)
Southern California (107)
Texas (13)
Washington State (22)
31,599 Results for "ars".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia
December 13, 2024
·
8 min read
Approvals
ARS Pharma Gets FDA Green Light for First Nasal Spray for Severe Allergic Reactions
ARS Pharma’s neffy on Friday became the first FDA-approved nasal spray to address severe allergic reactions, including those that might lead to life-threatening anaphylaxis.
August 12, 2024
·
2 min read
·
Tristan Manalac
Press Releases
ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
·
1 min read
Press Releases
ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 14, 2024
·
16 min read
Policy
ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions (anaphylaxis)
ARS Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion on the application for marketing authorization for EURneffy® and recommended related market authorization in the European Union for the emergency treatment of allergic reactions.
June 28, 2024
·
6 min read
Drug Development
Arthrosi Presents Positive Phase 2 Data for AR882 at the European Alliance of Associations for Rheumatology (EULAR) Congress 2024
Arthrosi Therapeutics, Inc. announced new positive clinical data from its phase 2 AR882-203 study in patients with tophaceous gout.
June 14, 2024
·
7 min read
Business
ARS Pharmaceuticals to Participate in the 2024 Cantor Global Healthcare Conference
September 10, 2024
·
1 min read
Press Releases
ARS Pharmaceuticals Announces Planned Launch of neffyinSchools Program to Provide Life-Saving Needle Free Epinephrine to Eligible K-12 Schools at No Cost
December 4, 2024
·
11 min read
Business
ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results
ARS Pharmaceuticals, Inc., a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, reported business updates and financial results for the first quarter of 2024.
May 9, 2024
·
12 min read
Press Releases
ARS Pharmaceuticals Announces Conference Call and Webcasts for its Third Quarter 2024 Financial Results and Presentations at Upcoming Conferences
November 7, 2024
·
1 min read
1 of 3,160
Next
